GO:0006506 GPI anchor biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006506 describes the biosynthesis of glycosylphosphatidylinositol (GPI) anchors, glycolipid structures that attach many proteins to the cell membrane.
• The GPI anchor is built in the endoplasmic reticulum through a multi-step pathway involving at least 20 gene products, including the PIG family of proteins.
• GPI-anchored proteins are involved in signal transduction, cell adhesion, and immune recognition, and are implicated in diseases such as paroxysmal nocturnal hemoglobinuria and cancer.
• Trypanosome GPI biosynthesis is a validated drug target for African sleeping sickness.
• GPI anchor remodeling in the Golgi affects protein trafficking and membrane dynamics.
• CRISPR-based knockout, point mutation, and knock-in models are powerful tools to dissect GPI biosynthesis gene function and disease mechanisms.
Description
Glycosylphosphatidylinositol (GPI) anchors are complex glycolipids that covalently attach numerous proteins to the outer leaflet of the plasma membrane. The biosynthetic process that assembles these anchors, designated GO:0006506, is essential for the correct localization and function of a wide array of cell surface proteins. GPI-anchored proteins (GPI-APs) are found in all eukaryotes and play critical roles in signal transduction, cell adhesion, immune response, and development. Defects in GPI biosynthesis cause inherited disorders such as paroxysmal nocturnal hemoglobinuria (PNH) and multiple congenital anomalies-hypotonia-seizures syndrome (MCAHS). Understanding the molecular details of GPI anchor biosynthesis is therefore crucial for both basic cell biology and therapeutic development. The pathway has been extensively studied in mammalian cells, yeast, and protozoan parasites, revealing a conserved core machinery. Recent advances in CRISPR genome editing have enabled precise manipulation of GPI biosynthesis genes, accelerating research into their functions and disease relevance.
GPI anchor biosynthetic process At A Glance
| GO ID | GO:0006506 |
|---|---|
| GO term | GPI anchor biosynthetic process |
| Ontology | biological_process |
| Synonym | glycosylphosphatidylinositol biosynthesis; GPI anchor biosynthesis; GPI anchor formation; GPI anchor synthesis; GPI/GSI anchor biosynthesis |
| Major function | Synthesis of glycolipid anchors that attach proteins to the cell membrane |
| Subcellular location | Endoplasmic reticulum membrane (initial steps) and Golgi apparatus (remodeling) |
| Key enzymes | PIGA, PIGB, PIGC, PIGF, PIGG, PIGH, PIGK, PIGL, PIGM, PIGN, PIGO, PIGP, PIGQ, PIGS, PIGT, PIGU, PIGV, PIGW, PIGX, PIGY, DPM2, GPAA1 |
| Pathway steps | At least 10 enzymatic steps, including transfer of GlcNAc, deacetylation, acylation, mannosylation, ethanolamine phosphate addition, and transamidation |
| Disease associations | Paroxysmal nocturnal hemoglobinuria (PIGA), MCAHS syndromes (PIGN, PIGA, PIGT, etc.), cancer |
What Is GO:0006506?
GO:0006506, GPI anchor biosynthetic process, is defined as the chemical reactions and pathways that result in the formation of a glycosylphosphatidylinositol anchor. This anchor attaches certain proteins to the lipid bilayer of the cell membrane. The phosphatidylinositol group is linked via the C-6 hydroxyl of inositol to a carbohydrate chain, which is in turn linked to the protein through an ethanolamine phosphate group. The amino group of ethanolamine forms an amide bond with the C-terminal carboxyl of the protein. Some GPI anchors have variations on this canonical structure.
Why Is GPI anchor biosynthetic process Important in Cell Biology?
The GPI anchor biosynthetic process is essential for the correct membrane targeting and function of many cell surface proteins. GPI-anchored proteins are involved in diverse physiological processes, including immune recognition, signal transduction, and cell adhesion. Disruption of GPI biosynthesis leads to severe human diseases, such as PNH, a acquired hematopoietic stem cell disorder caused by somatic mutations in PIGA. Inherited mutations in other GPI biosynthesis genes cause developmental disorders with epilepsy and intellectual disability. Moreover, the GPI pathway is a validated drug target in parasitic protozoa, such as Trypanosoma brucei, the causative agent of sleeping sickness. Therefore, studying GO:0006506 provides insights into fundamental cell biology and offers opportunities for therapeutic intervention.
• GPI anchors are required for the membrane attachment of many proteins lacking transmembrane domains.
• GPI-anchored proteins function in signal transduction, cell adhesion, and immune response.
• Somatic mutations in PIGA cause paroxysmal nocturnal hemoglobinuria (PNH).
• Inherited defects in GPI biosynthesis genes lead to MCAHS and other neurodevelopmental disorders.
• The GPI pathway is essential for the virulence of Trypanosoma brucei and other parasites.
• GPI anchor remodeling in the Golgi regulates protein sorting and membrane dynamics.
• GPI-anchored proteins are implicated in cancer progression and metastasis.
• Prion protein, a GPI-anchored protein, is involved in neurodegenerative diseases.
• GPI biosynthesis enzymes are potential targets for anti-parasitic and anti-cancer drugs.
• CRISPR screens have identified GPI pathway genes as essential in various cell types.
What Happens During GPI anchor biosynthetic process?
Step 1: Transfer of N-acetylglucosamine to phosphatidylinositol
In simple terms: The first step attaches a sugar molecule to a lipid carrier in the ER membrane.
The GPI biosynthesis pathway begins in the endoplasmic reticulum (ER) with the transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI). This reaction is catalyzed by the enzyme complex GPI-GlcNAc transferase, which includes PIGA, PIGC, PIGH, PIGP, PIGQ, and PIGY. The product, GlcNAc-PI, is then deacetylated by PIGL to yield glucosamine-PI (GlcN-PI). This step is essential for subsequent acylation and mannosylation.
Step 2: Acylation and mannosylation
In simple terms: The lipid tail is modified and sugar building blocks are added to form the core glycan.
GlcN-PI is acylated by PIGW to form GlcN-(acyl)PI, which is then flipped into the ER lumen by an unknown flippase. In the lumen, PIGM adds the first mannose from dolichol-phosphate-mannose (DPM) to form Man1-GPI. PIGV and PIGB sequentially add the second and third mannose residues, generating Man3-GPI. These mannoses are transferred from DPM, which is synthesized by DPM1, DPM2, and DPM3.
Step 3: Addition of ethanolamine phosphate groups
In simple terms: Phosphate-containing ethanolamine groups are attached to the sugar chain.
Ethanolamine phosphate (EtNP) groups are added to the mannose residues by a series of transferases. PIGN adds EtNP to the first mannose, PIGG adds EtNP to the second mannose, and PIGO (with PIGF) adds EtNP to the third mannose. These modifications are crucial for recognition and attachment of the protein. The EtNP on the third mannose serves as the linkage point for the protein's C-terminus.
Step 4: Attachment of the protein and transamidation
In simple terms: The finished anchor is attached to the target protein, replacing its original tail.
Proteins destined for GPI anchoring have a C-terminal GPI attachment signal peptide. The transamidase complex, composed of PIGK, PIGS, PIGT, PIGU, and GPAA1, cleaves this signal peptide and simultaneously forms an amide bond between the ethanolamine phosphate on the GPI anchor and the new C-terminal amino acid of the protein. This reaction occurs in the ER lumen and results in the mature GPI-anchored protein.
Step 5: Remodeling in the Golgi apparatus
In simple terms: The anchor's lipid tails are modified to help the protein reach the cell surface.
After attachment, GPI-anchored proteins are transported to the Golgi apparatus, where the GPI anchor undergoes remodeling. The acyl chain on the inositol ring is removed by PGAP1, and the glycerol backbone may be replaced by a ceramide lipid by PGAP2 and PGAP3. This remodeling is important for the protein's association with lipid rafts and its subsequent trafficking to the plasma membrane.
Key Genes Involved in GO:0006506 GPI anchor biosynthetic process
The following genes encode enzymes and accessory proteins that catalyze the steps of GPI anchor biosynthesis.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIGA | Catalytic subunit of GPI-GlcNAc transferase; transfers GlcNAc to PI | Somatic mutations cause PNH; essential for GPI anchor synthesis |
| PIGB | Mannosyltransferase; adds third mannose to GPI | Mutations linked to developmental disorders |
| PIGC | Component of GPI-GlcNAc transferase | Required for first step; potential target for parasites |
| PIGF | Accessory protein for EtNP transfer to third mannose | Mutations cause MCAHS |
| PIGG | EtNP transferase; adds EtNP to second mannose | Defects associated with intellectual disability |
| PIGH | Component of GPI-GlcNAc transferase | Essential for GPI biosynthesis |
| PIGK | Catalytic subunit of GPI transamidase | Mutations cause neurodevelopmental disorders |
| PIGL | Deacetylase; converts GlcNAc-PI to GlcN-PI | Required for second step |
| PIGM | Mannosyltransferase; adds first mannose | Mutations cause GPI deficiency and epilepsy |
| PIGN | EtNP transferase; adds EtNP to first mannose | Mutations cause MCAHS |
| PIGO | EtNP transferase; adds EtNP to third mannose | Mutations cause MCAHS and hyperphosphatasia |
| PIGP | Component of GPI-GlcNAc transferase | Essential for GPI biosynthesis |
| PIGQ | Component of GPI-GlcNAc transferase | Mutations linked to epilepsy |
| PIGS | Component of GPI transamidase | Required for protein attachment |
| PIGT | Component of GPI transamidase | Mutations cause MCAHS with seizures |
| PIGU | Component of GPI transamidase | Essential for transamidation |
| PIGV | Mannosyltransferase; adds second mannose | Mutations cause MCAHS |
| PIGW | Acyltransferase; acylates GlcN-PI | Required for GPI biosynthesis |
| PIGX | Accessory protein for mannosylation | Potential regulator of GPI synthesis |
| PIGY | Component of GPI-GlcNAc transferase | Essential for first step |
| DPM2 | Subunit of DPM synthase; synthesizes dolichol-phosphate-mannose | Required for mannose donors |
| GPAA1 | Component of GPI transamidase | Required for protein attachment |
How Is GPI anchor biosynthetic process Regulated?
GPI anchor biosynthesis is regulated at multiple levels. The pathway is influenced by the availability of substrates such as phosphatidylinositol and dolichol-phosphate-mannose. Transcriptional regulation of GPI biosynthesis genes has been observed in response to cellular stress and during differentiation. In yeast, the unfolded protein response (UPR) regulates the expression of GPI biosynthesis genes to maintain ER homeostasis. Additionally, the activity of the GPI transamidase complex can be modulated by the availability of target proteins and the lipid environment. In mammalian cells, the PI3K/Akt/mTOR pathway has been implicated in controlling GPI-AP surface expression, although the exact mechanisms remain to be fully elucidated. Furthermore, GPI anchor remodeling in the Golgi is regulated by the PGAP family of proteins, which respond to cellular signals and lipid composition.
GPI anchor biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIGA | Paroxysmal nocturnal hemoglobinuria (PNH) | PIGA knockout hematopoietic stem cells; mouse models |
| PIGN | MCAHS with epilepsy | PIGN knockout mice; patient-derived iPSCs |
| PIGT | MCAHS with seizures | PIGT knockout cell lines; zebrafish models |
| PIGO | MCAHS with hyperphosphatasia | PIGO knockout mice; CRISPR knock-in of patient mutations |
| PIGV | MCAHS with developmental delay | PIGV knockout cell lines; Drosophila models |
Paroxysmal Nocturnal Hemoglobinuria (PNH)
PNH is an acquired hematopoietic stem cell disorder caused by somatic mutations in the PIGA gene, which is located on the X chromosome. PIGA mutations lead to a deficiency in GPI-anchored proteins on the surface of blood cells, including CD55 and CD59, which protect against complement-mediated lysis. This results in hemolytic anemia, thrombosis, and bone marrow failure. The absence of GPI-APs is a hallmark of PNH, and flow cytometry for GPI-APs is used for diagnosis.
Inherited GPI Deficiency Disorders (MCAHS)
Biallelic mutations in various GPI biosynthesis genes, such as PIGN, PIGA, PIGT, PIGO, PIGV, and PIGG, cause a group of rare neurodevelopmental disorders known as multiple congenital anomalies-hypotonia-seizures syndrome (MCAHS). These disorders are characterized by severe intellectual disability, epilepsy, hypotonia, and dysmorphic features. The severity depends on the specific gene and mutation, reflecting the partial activity of the GPI pathway.
Parasitic Infections
The GPI biosynthesis pathway is essential for the survival and virulence of protozoan parasites such as Trypanosoma brucei, the causative agent of African sleeping sickness. GPI-anchored proteins, including the variant surface glycoprotein (VSG), are critical for immune evasion. Inhibitors of GPI biosynthesis enzymes have shown promise as anti-parasitic drugs.
Cancer and Neurodegeneration
Altered expression of GPI-anchored proteins is associated with cancer progression, metastasis, and immune evasion. For example, the GPI-anchored protein CEA (carcinoembryonic antigen) is a tumor marker. In neurodegeneration, the prion protein (PrP), a GPI-anchored protein, is central to prion diseases. GPI anchor remodeling defects have also been linked to Alzheimer's disease and other neurodegenerative conditions.
From GPI anchor biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of PIGA loss on GPI-AP surface expression? | PIGA knockout in HEK293 or K562 cells |
| How do patient-specific PIGN mutations affect enzyme activity? | Point mutation knock-in of PIGN mutations in cell lines |
| Can we rescue GPI deficiency by expressing wild-type PIGT? | Knock-in of PIGT cDNA into PIGT-null cells |
| What is the interactome of GPI transamidase components? | Tagged knock-in of PIGK, PIGS, PIGT, PIGU, GPAA1 |
| Does overexpression of PIGM increase GPI anchor levels? | Overexpression of PIGM in mammalian cells |
| Which genes are essential for GPI biosynthesis in a genome-wide screen? | CRISPR knockout library screening in haploid cells |
How to Study the GPI anchor biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Genes essential for GPI-AP surface expression | Discovery of novel GPI pathway regulators |
| Flow cytometry | Surface levels of GPI-anchored proteins | Diagnosis of PNH; validation of gene knockouts |
| Metabolic labeling | Synthesis and processing of GPI intermediates | Analysis of pathway defects |
| Mass spectrometry | Structure and composition of GPI anchors | Characterization of remodeling and lipid modifications |
| AP-MS / BioID | Protein-protein interactions of GPI enzymes | Mapping of GPI biosynthesis complexes |
| RNA-seq | Transcriptional changes in GPI pathway genes | Response to stress or differentiation |
| Immunofluorescence microscopy | Subcellular localization of GPI enzymes and GPI-APs | ER/Golgi trafficking studies |
CRISPR Knockout Screens
Genome-wide CRISPR knockout screens have been used to identify genes required for GPI anchor biosynthesis and GPI-AP surface expression. For example, a screen using a GPI-AP reporter (e.g., CD59) can identify essential genes. This approach is powerful for discovering novel regulators and validating known pathway components.
Flow Cytometry for GPI-AP Detection
Flow cytometry using antibodies against GPI-anchored proteins (e.g., CD55, CD59) or fluorescently labeled proaerolysin (which binds GPI anchors) is a standard method to assess GPI anchor biosynthesis in cells. This technique is used clinically for PNH diagnosis and in research to quantify GPI-AP surface levels.
Metabolic Labeling and Mass Spectrometry
Metabolic labeling with radioactive precursors (e.g., [3H]mannose or [3H]glucosamine) followed by immunoprecipitation or thin-layer chromatography can analyze GPI anchor intermediates. Mass spectrometry-based lipidomics can characterize GPI anchor structures and remodeling.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry (AP-MS) of tagged GPI biosynthesis enzymes can reveal protein-protein interactions and complex composition. Proximity labeling (BioID) can identify transient interactors in the ER membrane.
How CRISPR Can Be Used to Study GO:0006506 GPI anchor biosynthetic process
Knockout
CRISPR knockout of GPI biosynthesis genes (e.g., PIGA, PIGT) in cell lines abolishes GPI anchor synthesis, leading to loss of GPI-APs from the cell surface. These models are used to study the consequences of GPI deficiency, such as complement sensitivity in PNH, and to validate drug targets.
Point Mutation
CRISPR-mediated point mutations can recreate patient-specific missense mutations in GPI genes (e.g., PIGN, PIGV) to study their impact on enzyme activity and protein stability. This approach helps to understand genotype-phenotype correlations in inherited GPI deficiencies.
Knock-in
Knock-in of tagged GPI biosynthesis genes (e.g., GFP or HA tags) allows for real-time imaging and biochemical analysis of the enzymes in their native context. Knock-in of wild-type cDNA into knockout cells can rescue the phenotype and confirm gene function.
Overexpression
Overexpression of GPI biosynthesis genes (e.g., PIGM, PIGA) can increase GPI anchor production and enhance surface expression of GPI-APs. This is useful for producing large amounts of GPI-APs for structural or functional studies, and for investigating the effects of pathway upregulation.
How EDITGENE Supports GPI anchor biosynthetic process Research
Researchers studying GPI anchor biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in the pathway, how mutations affect enzyme function, and whether restoring gene activity can rescue cellular phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and efficiency.
Contact EDITGENE today to design your custom CRISPR model for GPI anchor biosynthetic process research.
Frequently Asked Questions About GPI anchor biosynthetic process
What is GPI anchor biosynthetic process?
GPI anchor biosynthetic process (GO:0006506) is the series of enzymatic reactions that build a glycosylphosphatidylinositol anchor, a glycolipid that attaches certain proteins to the cell membrane.
What genes are involved in GPI anchor biosynthetic process?
Key genes include PIGA, PIGB, PIGC, PIGF, PIGG, PIGH, PIGK, PIGL, PIGM, PIGN, PIGO, PIGP, PIGQ, PIGS, PIGT, PIGU, PIGV, PIGW, PIGX, PIGY, DPM2, and GPAA1.
Where does GPI anchor biosynthesis occur?
The initial steps occur in the endoplasmic reticulum membrane, and remodeling occurs in the Golgi apparatus.
What diseases are associated with defects in GPI anchor biosynthesis?
Defects cause paroxysmal nocturnal hemoglobinuria (PNH), multiple congenital anomalies-hypotonia-seizures syndrome (MCAHS), and are implicated in cancer and parasitic infections.
How is GPI anchor biosynthesis regulated?
It is regulated by substrate availability, transcriptional control, the unfolded protein response, and Golgi remodeling enzymes.
What methods are used to study GPI anchor biosynthesis?
Common methods include CRISPR knockout screens, flow cytometry, metabolic labeling, mass spectrometry, and proteomics.
Can CRISPR be used to model GPI anchor biosynthesis defects?
Yes, CRISPR knockout, point mutation, and knock-in models are widely used to study GPI gene function and disease mechanisms.
What is the role of PIGA in GPI anchor biosynthesis?
PIGA is the catalytic subunit of the GPI-GlcNAc transferase complex, which catalyzes the first step of GPI anchor biosynthesis.
How does GPI anchor remodeling affect protein trafficking?
Remodeling in the Golgi, mediated by PGAP proteins, influences lipid raft association and trafficking of GPI-anchored proteins to the plasma membrane.
Is GPI anchor biosynthesis a drug target?
Yes, the pathway is a validated target in protozoan parasites like Trypanosoma brucei, and inhibitors are being explored for anti-parasitic therapy.
Conclusion
The GPI anchor biosynthetic process (GO:0006506) is a fundamental cellular pathway that attaches a diverse array of proteins to the cell membrane. Its correct function is essential for normal development, immune response, and tissue homeostasis, and its disruption leads to severe human diseases. Continued research using advanced CRISPR models and high-throughput screening will further illuminate the molecular details of this pathway and facilitate the development of targeted therapies.
References
- 1. Kinoshita T. 2020. Biosynthesis and biology of mammalian GPI-anchored proteins.. Open Biol 10(3):190290 PMID: 32156170
- 2. Brown D et al.. 1992. Glycosyl-phosphatidylinositol-anchored membrane proteins.. J Am Soc Nephrol 3(4):895-906 PMID: 1450366
- 3. Yadav U et al.. 2018. Targeting the GPI biosynthetic pathway.. Pathog Glob Health 112(3):115-122 PMID: 29484956
- 4. Ikezawa H. 2002. Glycosylphosphatidylinositol (GPI)-anchored proteins.. Biol Pharm Bull 25(4):409-17 PMID: 11995915
- 5. Hong Y et al.. 2009. Trypanosome glycosylphosphatidylinositol biosynthesis.. Korean J Parasitol 47(3):197-204 PMID: 19724691
- 7. Sarnataro D et al.. 2017. Cell Biology of Prion Protein.. Prog Mol Biol Transl Sci 150:57-82 PMID: 28838675
- 8. Fujita M et al.. 2012. GPI-anchor remodeling: potential functions of GPI-anchors in intracellular trafficking and membrane dynamics.. Biochim Biophys Acta 1821(8):1050-8 PMID: 22265715
